Oxycodone

Oxycodone

SCHEMBL16015666

COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CC[C@@]314

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Oxycodone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 known ✓ P35372 8/20 1.00
▸ OPRD1 P41143 7/20 1.00
▸ OPRK1 P41145 6/20 1.00
▸ ALDH1A1 P00352 1/20 0.75
▸ CYP3A4 P08684 1/20 0.75
▸ CYP2D6 P10635 1/20 0.75
▸ TSHR P16473 1/20 0.75
▸ HSD17B10 Q99714 1/20 0.75
▸ LMNA P02545 1/20 0.74
▸ BLM P54132 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxycodone SCHEMBL3121359 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL12945207 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL12960967 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL618773 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL14394071 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL4104773 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL8386507 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL18410410 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL22058352 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4
Oxycodone SCHEMBL22163723 1.00 OPRM1 (1.00) OPRM1OPRD1OPRK1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829020-B2 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers MALLINCKRODT LLC (US) 2014-09-09 — — US disclosed
Send feedback